JP2006096671A - Skin activation agent - Google Patents

Skin activation agent Download PDF

Info

Publication number
JP2006096671A
JP2006096671A JP2004280893A JP2004280893A JP2006096671A JP 2006096671 A JP2006096671 A JP 2006096671A JP 2004280893 A JP2004280893 A JP 2004280893A JP 2004280893 A JP2004280893 A JP 2004280893A JP 2006096671 A JP2006096671 A JP 2006096671A
Authority
JP
Japan
Prior art keywords
skin
colostrum
activation
polyhydric alcohol
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004280893A
Other languages
Japanese (ja)
Inventor
Kenji Uchida
健志 内田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2004280893A priority Critical patent/JP2006096671A/en
Publication of JP2006096671A publication Critical patent/JP2006096671A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a skin activation agent heated at 30-45°C when brought into contact with the skin and effective for improving the skin activity (activation of metabolism and improvement of aesthetic quality) by the promotion of blood flow while effectively warming the skin and keeping the skin temperature to a level to maximize the cell activation action of the colostrum of mammals. <P>SOLUTION: The skin activation agent contains the colostrum of a mammal and a polyhydric alcohol and generates heat on the human skin at 30-45°C. The colostrum of mammal is obtained representatively from dairy cattle, however, the colostrum of human, goat, sheep, horse, camel, etc., is also usable. The colostrum of mammals is preferably defatted for improving the storage stability and pulverized by spray drying or freeze drying. The defatting, spray drying and freeze drying process for producing powdery colostrum can be carried out according to conventional method. Any polyhydric alcohol generating hydration heat by contacting with water can be used in the invention and the examples of the alcohol are propylene glycol, glycerol, etc., especially preferably glycerol. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、皮膚に接触させたとき30〜45℃に発熱し、肌を効果的に温めながら血行を促進し、有効成分である哺乳動物の初乳の細胞活性化作用を最も高める温度にすることにより、肌の活性化(新陳代謝の活発化、美観の向上)を一段と高める作用を有する皮膚活性化剤に関する。   The present invention generates heat at 30 to 45 ° C. when brought into contact with the skin, promotes blood circulation while effectively warming the skin, and makes the cell activation effect of the colostrum of the mammal which is an active ingredient the highest. It is related with the skin activating agent which has the effect | action which raises the activation (activation of a metabolism, the improvement of aesthetics) of skin further.

皮膚に対して薬剤で発熱を与えると、温熱効果と総称される種々の効用、例えば温感に基づく塗布時の快感、血行の促進による肌の活性化(疲労回復、新陳代謝の活発化、美観の向上等)、毛穴の拡張や熱による表皮汚れの除去性向上といった効果、さらに化粧料が薬剤を含有する場合には、発熱が薬剤の皮膚浸透性を促進させる効果などを得ることが期待できる。このような効用をもたらすような発熱性を付与する手段として、従来より酸化還元反応、中和反応、水和反応等の化学反応の応用が検討されているが、これらのうち、水和反応は、劇薬を使用しないために安全性が高く、当該分野への適用が最も好ましい発熱手段である。   When a fever is given to the skin by a drug, various effects collectively referred to as a thermal effect, for example, a pleasant feeling at the time of application based on a warm feeling, activation of the skin by promoting blood circulation (fatigue recovery, activation of metabolism, aesthetic appearance) Improvement), the effect of expanding pores and improving the removal property of epidermis due to heat, and further, when the cosmetic contains a drug, heat generation can be expected to have the effect of promoting the skin permeability of the drug. As means for imparting exothermic properties that bring about such effects, the application of chemical reactions such as oxidation-reduction reactions, neutralization reactions, and hydration reactions has been conventionally studied. Since it does not use powerful drugs, it is highly safe and is the most preferable heating means to be applied in this field.

皮膚への発熱付与の具体例としては、水性粘性体からなる第1剤と酸化カルシウムを油剤中に分散させた第2剤を用時に混合することによって発生する熱を利用して、除毛成分を迅速に毛根部分に作用させる方法が開示されている(特許文献1参照)。この方法においては、酸化カルシウムが水と反応して水酸化カルシウムに変化する際の発熱が利用されている。   As a specific example of imparting heat generation to the skin, a hair removal component utilizing heat generated by mixing a first agent composed of an aqueous viscous material and a second agent in which calcium oxide is dispersed in an oil during use. Has been disclosed (see Patent Document 1). In this method, heat generated when calcium oxide reacts with water and changes to calcium hydroxide is used.

また焼き石膏を主成分とした無水の無機塩類が結晶水を吸蔵する際の発熱を利用したパック化粧料が提案されている(特許文献2、特許文献3、特許文献4参照)。このような無機塩類の水和反応は、単位重量当たりの発熱量が比較的大きいという特徴を有するものの、無機塩類が用時以前に水分と接触するのを防ぎかつ化粧料の形状を保持する目的で使用されている非水性媒質の親水性・熱伝導性が不充分であるため、温熱効果は必ずしも満足できるものではなかった。   Further, pack cosmetics using heat generated when anhydrous inorganic salts mainly composed of calcined gypsum occlude crystal water have been proposed (see Patent Document 2, Patent Document 3, and Patent Document 4). Although the hydration reaction of such inorganic salts has a feature that the calorific value per unit weight is relatively large, the purpose of preventing the inorganic salts from coming into contact with moisture before use and maintaining the shape of the cosmetic. The thermal effect was not always satisfactory because the non-aqueous medium used in No. 1 had insufficient hydrophilicity and thermal conductivity.

さらに、活性化ゼオライトの水和熱を利用した化粧料等も公知である(特許文献5、特許文献6、特許文献7参照)。これらの化粧料には、活性化ゼオライトを分散する目的でポリオール類やポリエチレングリコールが使用されているほか、配合安定化の見地から、活性化ゼオライトに対して予めイオン交換処理を行うことも提案されている。しかしながら、これら公知の化粧料は、水を混合した瞬間に発熱が終了するので、発熱を5分以上持続させるためには活性化ゼオライトを高濃度で分散させる必要があり、経済性、製造操作の点で不便であった。しかも、活性化ゼオライトを高濃度で配合した化粧料は、水混合と同時に一時的に高温になるため、皮膚上に火傷を起こす等、安全性の面でも問題があった。   Furthermore, cosmetics using the heat of hydration of activated zeolite are also known (see Patent Document 5, Patent Document 6, and Patent Document 7). In these cosmetics, polyols and polyethylene glycol are used for the purpose of dispersing the activated zeolite, and from the viewpoint of stabilizing the formulation, it is also proposed to perform ion exchange treatment on the activated zeolite in advance. ing. However, since these known cosmetics generate heat at the moment of mixing water, it is necessary to disperse the activated zeolite at a high concentration in order to maintain the heat generation for 5 minutes or more. It was inconvenient in terms. Moreover, cosmetics formulated with a high concentration of activated zeolite have a problem in terms of safety, such as causing burns on the skin because the temperature temporarily increases simultaneously with water mixing.

一方、哺乳動物の初乳は、皮膚再生化作用や細胞活性化作用を示すことが報告されており、細胞活性化剤として期待されているが、我が国では未だ使用が許されておらず、研究がすすんでいない。加えて、上記作用の程度がまちまちであり、どのような条件で細胞活性化効果が高まるか未だ解決されていない問題点が多い。
特開昭51−104043号公報 特開昭57−114506号公報、 特開昭62−30704号公報 特開昭63−54308号公報 特開平4−89424号公報 欧州特許第187912号明細書 米国特許第3250680号明細書
On the other hand, mammalian colostrum has been reported to exhibit skin regeneration and cell activation, and is expected as a cell activator. I'm not going. In addition, the degree of the above action varies, and there are many problems that have not been solved yet under what conditions the cell activation effect is enhanced.
Japanese Patent Laid-Open No. 51-104043 JP-A-57-114506, JP 62-30704 A JP-A 63-54308 JP-A-4-89424 EP 187912 Specification U.S. Pat. No. 3,250,680

従って、哺乳動物の初乳の細胞活性化効果を高めるため、どのような条件、例えばどのような温度で皮膚上に与えることが適当であるのかを探求することが重要である。すなわち、適温に肌を温める効果に優れつつ、哺乳動物の初乳の皮膚再生化(細胞活性化)を効果的に促進できる皮膚活性化剤が望まれている。   Therefore, it is important to explore what conditions, for example, what temperature is appropriate to apply on the skin, in order to enhance the cell activation effect of mammalian colostrum. That is, there is a demand for a skin activating agent that can effectively promote skin regeneration (cell activation) of mammalian colostrum while being excellent in the effect of warming the skin to an appropriate temperature.

本発明はこのような課題を解決すべく工夫されたものである。   The present invention has been devised to solve such problems.

かかる実情において、本発明者らは鋭意研究を行った結果、有効成分が哺乳動物の初乳であり、かつ、多価アルコールを含有し、人の皮膚上で30〜45℃に発熱する皮膚活性化剤であって、さらに好ましくは牛の初乳を有効成分とし、かつ、グリセリンを含有することによって、人の皮膚上で、10〜15分、30〜45℃の適温に発熱し、哺乳動物の初乳の皮膚活性化効果を高めることを特徴とする皮膚活性化剤が得られることを見出し、本発明を完成した。   In this situation, the present inventors have conducted intensive research. As a result, the active ingredient is mammalian colostrum, contains polyhydric alcohol, and has a skin activity that generates heat at 30 to 45 ° C. on human skin. It is an agent, and more preferably, by containing bovine colostrum as an active ingredient and containing glycerin, fever occurs at a suitable temperature of 30 to 45 ° C. for 10 to 15 minutes on human skin, and the mammal It was found that a skin activating agent characterized by enhancing the skin activating effect of colostrum was obtained, and the present invention was completed.

すなわち、本発明による皮膚活性化剤は、哺乳動物の初乳と多価アルコールを含有し、人の皮膚上で30〜45℃に発熱することを特徴とするものである。     That is, the skin activating agent according to the present invention contains mammalian colostrum and polyhydric alcohol, and generates heat at 30 to 45 ° C. on human skin.

本発明による皮膚活性化剤は、医薬品、医薬部外品または化粧品であってよい。     The skin activating agent according to the present invention may be a pharmaceutical, a quasi drug or a cosmetic.

本発明に用いられる哺乳動物の初乳は、代表的には乳牛から得られるものであるが、ヒト、ヤギ、ヒツジ、ウマ、ラクダなどの初乳も利用可能である。   The colostrum of mammals used in the present invention is typically obtained from dairy cows, but colostrum such as humans, goats, sheep, horses and camels can also be used.

哺乳動物の初乳は、保存安定性を高めるため脱脂した後、得られる脱脂初乳を噴霧乾燥ないし凍結乾燥により粉末化することが好ましい。初乳の粉末を得るための脱脂、噴霧乾燥、凍結乾燥などは常法に従って行うことができる。 Mammalian colostrum is preferably defatted in order to enhance storage stability, and then the defatted colostrum obtained is powdered by spray drying or freeze drying. Degreasing, spray drying, freeze drying and the like for obtaining colostrum powder can be performed according to conventional methods.

本発明に用いられる多価アルコールは、プロピレングリコール、グリセリン等、水分との接触により水和熱を発生させるものであればよく、好ましくはグリセリンである。   The polyhydric alcohol used for this invention should just generate | occur | produce a heat | fever of hydration by contact with moisture, such as propylene glycol and glycerol, Preferably it is glycerol.

さらに、本発明の皮膚活性化剤には、その他通常一般的に使用されている医薬品及び医薬品添加物、化粧品原料など、例えば、ビタミン類、鎮痛消炎剤、ステロイド類、無機塩類、無機酸類、薬草類、界面活性剤、アルコール類、油脂類、色素類、香料などを本発明の効果を妨げない限り、適宜な量で添加することができる。   Furthermore, the skin activating agent of the present invention includes other commonly used pharmaceuticals and pharmaceutical additives, cosmetic raw materials, etc., such as vitamins, analgesic / anti-inflammatory agents, steroids, inorganic salts, inorganic acids, herbs. As long as they do not interfere with the effects of the present invention, surfactants, surfactants, alcohols, fats and oils, pigments, fragrances and the like can be added in appropriate amounts.

ビタミン類は、各種ビタミンおよびその誘導体であってよく、ビタミンA、ビタミンC、ビタミンEならびにその誘導体であることが好ましい。   The vitamins may be various vitamins and derivatives thereof, and are preferably vitamin A, vitamin C, vitamin E and derivatives thereof.

鎮痛消炎剤はインドメタシン、イブプロフェン、ケトプロフェンなどであってよい。   The analgesic / anti-inflammatory agent may be indomethacin, ibuprofen, ketoprofen and the like.

ステロイド類は、ハイドロコーチゾン、ベータメサゾンなどであってよい。   Steroids may be hydrocortisone, betamethasone, and the like.

無機塩類は、塩化ナトリウム、炭酸水素ナトリウム、炭類ナトリウム、硫酸ナトリウム、チオ硫酸ナトリウム、炭酸カルシウム、炭酸マグネシウム、硫化カリウム、臭化カリウム、塩化カルシウム、硫酸アルミニウム、タルク、酸化亜鉛、ホウ酸、無水ケイ酸、メタケイ酸などであってよい。   Inorganic salts include sodium chloride, sodium bicarbonate, sodium carbonate, sodium sulfate, sodium thiosulfate, calcium carbonate, magnesium carbonate, potassium sulfide, potassium bromide, calcium chloride, aluminum sulfate, talc, zinc oxide, boric acid, anhydrous It may be silicic acid, metasilicic acid or the like.

薬草類は、ウイキョウ、黄柏(オウバク)、カミツレ、桂皮(ケイヒ)、当帰(トウキ)、薄荷(ハッカ)、菖蒲(ショウブ)、芍薬(シャクヤク)、トウヒ、十薬(ジュウヤク)、サンショウ、竜脳(リュウノウ)などであってよい。   Herbs include fennel, jaundice, chamomile, cinnamon bark, toki, thin load (pepper), cocoon (pepper), glaze (peony), spruce, ten-pound (jujuyaku), salamander, It may be a dragon brain.

界面活性剤は、公知のアニオン系界面活性剤、ノニオン系界面活性剤、カチオン系界面活性剤、両性界面活性剤のいずれでもよい。   The surfactant may be any of a known anionic surfactant, nonionic surfactant, cationic surfactant, and amphoteric surfactant.

アルコール類は、エタノール、ステアリルアルコール、イソプロピルアルコール、セチルアルコールなどであってよい。   The alcohol may be ethanol, stearyl alcohol, isopropyl alcohol, cetyl alcohol, and the like.

油脂類は、オリーブ油、大豆油、米ヌカ油、サフラワー油、流動パラフィンなどであってよい。   The fats and oils may be olive oil, soybean oil, rice bran oil, safflower oil, liquid paraffin, and the like.

色素類、香料類は、天然品、合成品またはそれらの混合のいずれでもよい。   The pigments and fragrances may be natural products, synthetic products, or a mixture thereof.

本発明による皮膚活性化剤は、人の皮膚上に適用されたとき、30〜45℃に発熱すればよく、これによって有効成分である哺乳動物の初乳の活性効果が高まり、皮膚の活性化効果が有効に適用される。この温度での発熱は、10〜15分間続くことが好ましい。   The skin activating agent according to the present invention only needs to generate heat at 30 to 45 ° C. when applied on human skin, thereby increasing the active effect of mammalian colostrum, which is an active ingredient, and activating the skin. The effect is applied effectively. Heat generation at this temperature preferably lasts for 10-15 minutes.

発熱温度が35℃より低いと、皮膚活性化が十分になされず、45℃を越えると皮膚が損傷をきたす恐れがある。   If the exothermic temperature is lower than 35 ° C, the skin is not sufficiently activated, and if it exceeds 45 ° C, the skin may be damaged.

本発明の好適な実施形態では、哺乳動物が牛であって、多価アルコールがグリセリンである場合、牛の初乳を6〜60重量%、グリセリンを40〜94重量%の割合で組み合わせればよく、人の皮膚上に皮膚活性化剤5gを面積5cm2に塗り広げればよい(有効成分TGFは0.35〜3.5μg/cm2で効果を発揮する。初乳にTGFは5.8μg/g含有されればよい。)。 In a preferred embodiment of the present invention, when the mammal is a cow and the polyhydric alcohol is glycerin, the colostrum of the cow is combined at a ratio of 6 to 60% by weight and glycerin at a ratio of 40 to 94% by weight. Well, it is only necessary to spread 5g 2 of skin activating agent on human skin (active ingredient TGF is effective at 0.35-3.5μg / cm 2. Colostrum contains 5.8μg / g of TGF. Just do it.)

グリセリンは、40〜60重量%の配合割合で発熱する。さらに温度を上げる場合は塩化マグネシウムを加える。   Glycerin generates heat at a blending ratio of 40 to 60% by weight. Add magnesium chloride to further increase the temperature.

皮膚活性化剤により生じた熱が30〜45℃で10〜15分間皮膚に与えられることにより、有効成分の皮膚への活性が高められ、皮膚の活性化が促進される。   When the heat generated by the skin activating agent is applied to the skin at 30 to 45 ° C. for 10 to 15 minutes, the activity of the active ingredient on the skin is increased and the activation of the skin is promoted.

本発明の皮膚活性化剤の剤型は、特に限定されず、ローション剤、乳液剤、クリーム剤、ジェル剤、ペースト剤、パック剤、プラスター剤、軟膏剤、固体剤などの形態をとることが可能である。これらの剤型を調製するには、それぞれ公知の基剤が用いられる。炭酸ガス、窒素ガスなどの圧縮ガスまたはLPGなどの液化ガスを使用し、エアゾール容器から吐出するエアゾール剤の形態をとることも可能である。   The dosage form of the skin activator of the present invention is not particularly limited, and may take the form of a lotion, emulsion, cream, gel, paste, pack, plaster, ointment, solid, etc. Is possible. In preparing these dosage forms, known bases are used. It is also possible to use a compressed gas such as carbon dioxide gas or nitrogen gas or a liquefied gas such as LPG and take the form of an aerosol agent discharged from an aerosol container.

本発明の皮膚活性化剤は、発熱性及びその持続性に優れ、発熱効果により、有効成分である哺乳動物の初乳の効果を向上させ、人の皮膚に効果的に皮膚活性化作用を与えることができ、また温感による塗布時の感じが良く、血行の促進による肌の活性化、湿潤状態による擦過傷などの治癒効果にも優れたものである。   The skin activating agent of the present invention is excellent in pyrogenicity and its sustainability, and improves the effect of mammalian colostrum, which is an active ingredient, by the pyrogenic effect, and effectively gives skin activating action to human skin In addition, it has a good feeling when applied due to warm feeling, and also has excellent healing effects such as skin activation by promoting blood circulation and abrasion due to wet conditions.

次に、実施例を挙げて本発明をさらに説明するが、本発明はこれら実施例に限定されるものではない。   EXAMPLES Next, although an Example is given and this invention is further demonstrated, this invention is not limited to these Examples.

実施例1
乳牛から得られた初乳を脱脂した後、得られる脱脂初乳を噴霧乾燥により粉末化したものと、グリセリンとローション用基剤を混合してローション剤を製造した。これを哺乳動物の皮膚に一定量接触させ、皮膚表面の皮膚活性化を測定した。
Example 1
After degreasing the colostrum obtained from dairy cows, a lotion preparation was prepared by mixing the defatted colostrum obtained by pulverization with glycerin and a lotion base. A certain amount of this was brought into contact with mammalian skin, and skin activation on the skin surface was measured.

その結果、ローション剤を塗布した皮膚の表面では30〜45℃の温度が塗布開始0.5分後から10分後にわたって持続し、かつ、比較例に比べ、皮膚活性化が促進された。


As a result, the temperature of 30 to 45 ° C. lasted from 0.5 minutes to 10 minutes after the start of application on the surface of the skin to which the lotion agent was applied, and skin activation was promoted as compared with the comparative example.


Claims (4)

哺乳動物の初乳と多価アルコールを含有し、人の皮膚上で30〜45℃に発熱することを特徴とする皮膚活性化剤。   A skin activating agent containing mammalian colostrum and polyhydric alcohol, and generating heat at 30 to 45 ° C. on human skin. 哺乳動物が牛であることを特徴とする請求項1記載の皮膚活性化剤。   The skin activating agent according to claim 1, wherein the mammal is a cow. 多価アルコールがグリセリンであることを特徴とする請求項1または2記載の皮膚活性化剤。   The skin activating agent according to claim 1 or 2, wherein the polyhydric alcohol is glycerin. 医薬品、医薬部外品または化粧品であることを特徴とする請求項1〜3のいずれかに記載の皮膚活性化剤。
The skin activating agent according to any one of claims 1 to 3, which is a pharmaceutical, a quasi-drug, or a cosmetic.
JP2004280893A 2004-09-28 2004-09-28 Skin activation agent Pending JP2006096671A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004280893A JP2006096671A (en) 2004-09-28 2004-09-28 Skin activation agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004280893A JP2006096671A (en) 2004-09-28 2004-09-28 Skin activation agent

Publications (1)

Publication Number Publication Date
JP2006096671A true JP2006096671A (en) 2006-04-13

Family

ID=36236821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004280893A Pending JP2006096671A (en) 2004-09-28 2004-09-28 Skin activation agent

Country Status (1)

Country Link
JP (1) JP2006096671A (en)

Similar Documents

Publication Publication Date Title
TWI327474B (en) Kit for preparation of carbon dioxide agent for external use.
US20050048090A1 (en) Temperature changing skin care product
JP2001019606A5 (en)
JP2003055146A (en) Cosmetic for massage having cool down effect
BRPI1001318A2 (en) freeze-dried molded article containing magnesium ascorbyl phosphate
BR112014032000B1 (en) COSMETIC COMPOSITION, COSMETIC PROCESS AND COSMETIC USE OF COMPOSITION
JPH06100411A (en) Cosmetic
JP2016008181A (en) Kit for skin external preparation
BR112014032054B1 (en) cosmetic makeup, cosmetic process and cosmetic makeup use
JP2008106043A (en) Oil-in-water (o/w) type emulsion cosmetic
JPS63310807A (en) Foamable cosmetic
BR112014032065B1 (en) COSMETIC AND / OR DERMATOLOGICAL COMPOSITION, COSMETIC PROCESS AND COSMETIC USE OF COMPOSITION
BR112015025476B1 (en) COMPOSITION, PROCESS FOR COSMETIC TREATMENT AND USE OF A COMPOSITION
JPH1160460A (en) Skin cosmetic
JP4286436B2 (en) Pyrogenic particles
JP5692618B1 (en) Skin preparation kit
JP5643872B2 (en) Carbon dioxide transdermal / mucosal absorption composition
RU2016142284A (en) INDEPENDENT CHEMICAL FOAM CONTAINING ADAPALENE AND BENZOYL PEROXIDE
JP2004065949A (en) Exothermic particles, exothermic compound and exothermic sheet using this compound
JP2006096671A (en) Skin activation agent
JP2022095943A (en) Foamable skin external preparation kit
JP2012149024A (en) Composition for preparing carbon dioxide preparation for external use
JP4162305B2 (en) Topical thermal composition
JP2013177384A (en) Keratin releasing composition
JP2004123638A (en) Cosmetic for massaging nail

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070928

A977 Report on retrieval

Effective date: 20090909

Free format text: JAPANESE INTERMEDIATE CODE: A971007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090915

A02 Decision of refusal

Effective date: 20100216

Free format text: JAPANESE INTERMEDIATE CODE: A02